This activity was made possible in part by an educational grant from Novartis.

Summary

This is the third session in a four-part series, SHM Clinical Rapid Updates: Heart Failure. This session covers quality improvement focused approach for heart failure patient during hospitalization. Specific subtopics addressed in this session include:

1. Describe novel HF therapies that are potential QI targets including SGLT2 inhibitors alone and in combination w/ ANRI
2. Describe results of recent studies as potential QI targets including EMPRROR Reducediv and DAPA HFv
3. Discuss QI efforts in this area

This panel was moderated by Dr. Joseph Sweigart, MD, SFHM. Our panelists included Dr. Lily Ackerman, MD, ScM, Dr. Gurpreet Sodhi, MD, and Dr. Ebrahim Barkoudah, MD, FACP, MPH, SFHM.

Target Audience

This activity is designed for hospitalists. No prerequisites required.

Accreditation Statement

The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Statement Designation

The Society of Hospital Medicine designates this enduring internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: October 22, 2021

Expiration Date: October 22, 2022

Estimated time to complete: 1 hour

Conflict of Interest Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.

Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.

Off Label Product Discussion

All faculty have indicated that they have not referenced unlabeled or unapproved uses of drugs or devices.

Instructions

The following is an interactive educational module designed to help you gauge your basic knowledge of the topic and then direct you to areas you may need to focus on. It consists of several sections: a pre-test, a presentation, a post-test, & CME evaluation. All sections must be completed to receive CME credit.